April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Long Term Resveratrol Treatment Provides Differential Protection of Injured Retinal Ganglion Cell Dendrites
Author Affiliations & Notes
  • James D Lindsey
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, CA
  • Karen X Duong-Polk
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, CA
  • Dustin Hammond
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, CA
  • Christopher Kai-Shun Leung
    University Eye Center, Hong Kong Eye Center, Hong Kong, Hong Kong
  • Robert N Weinreb
    Hamilton Glaucoma Center, University of California San Diego, La Jolla, CA
  • Footnotes
    Commercial Relationships James Lindsey, None; Karen Duong-Polk, None; Dustin Hammond, None; Christopher Leung, None; Robert Weinreb, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 2668. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      James D Lindsey, Karen X Duong-Polk, Dustin Hammond, Christopher Kai-Shun Leung, Robert N Weinreb; Long Term Resveratrol Treatment Provides Differential Protection of Injured Retinal Ganglion Cell Dendrites. Invest. Ophthalmol. Vis. Sci. 2014;55(13):2668.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine whether long-term treatment with dietary resveratrol protects against retinal ganglion cell (RGC) dendrite retraction and reduction of dendrite branching complexity following optic nerve injury.

Methods: Transgenic mice expressing yellow fluorescent protein under the control of the Thy-1 promoter (Thy1-YFP mice) were fed either control diet (N=12) or the same diet supplemented with resveratrol (0.04% w/w, N=15) starting from one month of age and continuing until the end of the study 12 months later. After 11 months on these diets, fluorescent RGCs were imaged using a modified confocal scanning laser ophthalmoscope (mCSLO), then unilateral optic nerve crush was performed. Fluorescent RGCs were imaged by mCSLO weekly for the next 4 weeks. RGCs were assigned to one of six groups according to Leung et al. (IOVS 2011;52:1539). Total dendrite length and dendritic branching complexity were determined by filament analysis using Imaris. Complete loss of dendrites was assessed in Kaplan-Meier plots.

Results: Progressive loss of dendrite length was noted in RGCs Groups 1, 2, 3, 5, and 6. Group 4 RGCs were too rarely observed for analysis. Resveratrol significantly protected against this loss at weeks 1, 2, and 4 after crush in Group 5 RGCs (P=0.002, 0.003, 0.015, respectively, t-test). Significant transient protection against this loss was observed in Group 3 RGCs (P=0.012 at week 1 after crush). Resveratrol did not significantly slow the loss in dendrite length of Group 1, 2, and 6 RGCs. Sholl analysis showed resveratrol significantly delayed loss of dendrite branching complexity in Group 3 and Group 5 RGCs at one week after crush, but not at later time points (P=0.014 and 0.013, respectively). In contrast, complete loss of dendrites was significantly delayed in RGCs Groups 1, 2, 5, and 6 (P=0.019, 0.012, 0.011, and 0.0001, respectively; log rank test).

Conclusions: One year treatment with dietary resveratrol significantly protected against the loss of RGC dendrites following optic nerve crush. This protective effect delayed the complete loss of dendrites in most types of RGCs as well as delayed the rate of dendrite retraction and loss of branching complexity in Group 3 and Group 5 RGCs.

Keywords: 691 retina: proximal (bipolar, amacrine, and ganglion cells) • 615 neuroprotection • 551 imaging/image analysis: non-clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×